Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jul. 02, 2016		Jun. 27, 2015
Operating activities:
Net income	$ 2,835,720		$ 2,706,298
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	902,022		917,544
Provision for losses on accounts receivable	(7,051)		41,956
Loss (Gain) on sale and disposal of equipment and patents	7,686		(45,850)
Loss on disposal of other assets	3,863
Increase in cash value of life insurance	(106,036)		(110,567)
Deferred compensation	(64,657)		(61,138)
Stock compensation expense			19,978
Changes in operating assets and liabilities:
Accounts receivable	1,913,099		(1,860,815)
Inventories	690,735		546,957
Prepaid expenses and other assets	11,811		326,793
Accounts payable and accrued and sundry liabilities	(2,226,846)		1,525,254
Net cash provided by operating activities	3,960,346		4,006,410
Investing activities:
Purchases of property and equipment	(391,567)		(505,085)
Proceeds from sale of equipment and patents			47,339
Payments for other assets	(71,548)		(65,592)
Net cash used for investing activities	(463,115)		(523,338)
Financing activities:
Dividends paid	(1,311,105)		(4,302,391)
Proceeds of long-term debt	2,900,000
Repayment of long-term debt	(2,900,000)
Purchase and retirement of common stock	(209,880)
Common stock issued upon exercise of options			180,708
Net cash used for financing activities	(1,520,985)		(4,121,683)
Effect of exchange rates on cash	31,163		(67,633)
Increase (Decrease) in cash and cash equivalents	2,007,409		(706,244)
Cash and cash equivalents at beginning of period	1,224,026	[1]	6,865,931
Cash and cash equivalents at end of period	$ 3,231,435		$ 6,159,687

[1] The Balance Sheet at October 3, 2015, has been derived from the audited financial statements at that date.